Finance

Beta
Lists
LENZ:NASDAQ
Lenz Therapeutics Inc
6,77 US$
+4,15%
(+0,27) 1D
12 ივნ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LENZ...
Open
6,48 US$
High
6,86 US$
Low
6,48 US$
Mkt. cap
212,27 მლნ.
Avg. vol.
814,01 ათ.
Volume
0,00
52-wk high
50,19 US$
52-wk low
6,28 US$
EPS
-3,59 US$
Beta
0,58
Shares outstanding
31,35 მლნ.
No. of employees
152
Open
6,48 US$
High
6,86 US$
Low
6,48 US$
Mkt. cap
212,27 მლნ.
Avg. vol.
814,01 ათ.
Volume
0,00
52-wk high
50,19 US$
52-wk low
6,28 US$
EPS
-3,59 US$
Beta
0,58
Shares outstanding
31,35 მლნ.
No. of employees
152
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to LENZ in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for LENZ in the last 3 months.
Highest
Current 6,77 US$
60,00 US$ (+786,26%)
Average
32,20 US$ (+375,63%)
Lowest
12,00 US$ (+77,25%)
News stories
From sources across the web
About Lenz Therapeutics Inc
CEO-
Employees152
Founded2013
HeadquartersSolana Beach, კალიფორნია, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websitelenz-tx.com
Last report
11 მაი. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-1,32 US$ / -1,07 US$
-23,30%miss
Revenue / Est. (USD)
1,90 მლნ. / 1,76 მლნ.
+8,08%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
5,00 მლნ.
12,50 მლნ.
1,59 მლნ.
1,90 მლნ.
Cost of goods sold
-
-
418,00 ათ.
1,08 მლნ.
Cost of revenue
-
-
418,00 ათ.
1,08 მლნ.
Research and development expenses
9,06 მლნ.
3,79 მლნ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,80 მლნ.
27,60 მლნ.
39,63 მლნ.
44,96 მლნ.
Operating expense
21,86 მლნ.
31,39 მლნ.
39,63 მლნ.
44,96 მლნ.
Total operating expenses
21,86 მლნ.
31,39 მლნ.
40,05 მლნ.
46,04 მლნ.
Operating income
-16,86 მლნ.
-18,89 მლნ.
-38,46 მლნ.
-44,14 მლნ.
Other non operating income
199,00 ათ.
-14,00 ათ.
-417,00 ათ.
3,00 ათ.
EBT including unusual items
-14,41 მლნ.
-16,70 მლნ.
-35,89 მლნ.
-41,49 მლნ.
EBT excluding unusual items
-14,41 მლნ.
-16,70 მლნ.
-35,89 მლნ.
-41,49 მლნ.
Income tax expense
500,00 ათ.
-
2,00 ათ.
-
Effective tax rate
-3,47%
-
-0,01%
-
Other operating expenses
-
-
-
-
Net income
-14,91 მლნ.
-16,70 მლნ.
-35,90 მლნ.
-41,49 მლნ.
Net profit margin
-298,24%
-133,60%
-2 260,45%
-2 182,43%
Earnings per share
-0,53
-0,59
-1,16
-1,32
Interest and investment income
2,25 მლნ.
2,20 მლნ.
2,99 მლნ.
2,64 მლნ.
Interest expense
-
-
-
-
Net interest expenses
2,25 მლნ.
2,20 მლნ.
2,99 მლნ.
2,64 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,84 მლნ.
-18,76 მლნ.
-38,36 მლნ.
-44,02 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer